World's Best Scientists 2026 revealed!
Janet Dancey

Janet Dancey

D-Index & Metrics

Medicine

D-Index
89
Citations
62428
World Ranking
12409
National Ranking
504

Janet Dancey publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Janet Dancey sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 265 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Janet Dancey D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Janet Dancey sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Janet Dancey is affiliated with Queen's University in Canada and has contributed extensively to the field of medical research. Their work primarily focuses on oncology and related subfields, with significant attention to cancer immunotherapy, genomics, diagnostics, and lung cancer treatments.

Their research spans multiple domains within medicine, with notable emphasis on:

  • Oncology
  • Economics and Econometrics
  • Public Health, Environmental and Occupational Health
  • Cancer Research
  • Pulmonary and Respiratory Medicine

Janet Dancey's main topics of investigation include:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Health Systems, Economic Evaluations, Quality of Life
  • Ethics in Clinical Research
  • Economic and Financial Impacts of Cancer
  • Lung Cancer Treatments and Mutations
  • Biomedical Ethics and Regulation

The scientist has published multiple papers in notable journals, demonstrating research activity in clinical oncology and health evaluation. Selected recent papers are:

  • Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy, 2023, Journal of Clinical Oncology
  • ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results, 2023, Nature Medicine
  • CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC, 2021, Journal of Thoracic Oncology
  • CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada, 2021, Current Oncology
  • CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC), 2020, Journal of Clinical Oncology

Their work frequently appears in the following publication venues:

  • Journal of Clinical Oncology
  • Current Oncology
  • Journal of Thoracic Oncology
  • UNC Libraries
  • Nature Medicine

Janet Dancey has collaborated extensively with a number of coauthors, including:

  • Scott A. Laurie
  • Stephen Sundquist
  • Keyue Ding
  • Ming-Sound Tsao
  • Valsamo Anagnostou

Best Publications

  • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

    Elizabeth Eisenhauer;Patrick Therasse;Jan Bogaerts;L.H. Schwartz

  • Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

    Frances A. Shepherd;Janet Dancey;Rodryg Ramlau;Karin Mattson

  • iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

    Lesley Seymour;Jan Bogaerts;Andrea Perrone;Robert Ford

  • RECIST 1.1—Update and clarification: From the RECIST committee

    Lawrence H. Schwartz;Lawrence H. Schwartz;Saskia Litiere;Elisabeth G. E. de Vries;Robert Ford

  • Response assessment criteria for brain metastases: proposal from the RANO group

    Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani

  • Phase II Trial of Gefitinib in Recurrent Glioblastoma

    Jeremy N. Rich;David A. Reardon;Terry Peery;Jeannette M. Dowell

  • Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Jan C. Buckner;Matthew J. Maurer;Jeffrey I. Kreisberg

  • Issues and progress with protein kinase inhibitors for cancer treatment

    Janet Dancey;Edward A. Sausville

  • Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

    Malcolm J. Moore;J. Hamm;J. Dancey;P. D. Eisenberg

  • Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

    Susan M. Chang;Patrick Wen;Timothy Cloughesy;Harry Greenberg

  • mTOR signaling and drug development in cancer

    Janet Dancey

  • Strategies for optimizing combinations of molecularly targeted anticancer agents.

    Janet E. Dancey;Helen X. Chen

  • Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.

    Melanie B. Thomas;Romil Chadha;Katrina Glover;Xuemei Wang

  • The Genetic Basis for Cancer Treatment Decisions

    Janet E. Dancey;Philippe L. Bedard;Philippe L. Bedard;Nicole Onetto;Thomas J. Hudson;Thomas J. Hudson

  • Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.

    Kamal S. Saini;Kamal S. Saini;Sherene Loi;Evandro de Azambuja;Otto Metzger-Filho

  • A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

    Jeffrey J. Raizer;Lauren E. Abrey;Andrew B. Lassman;Susan M. Chang

  • Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

    Amit M. Oza;Laurie Elit;Ming-Sound Tsao;Suzanne Kamel-Reid

  • A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.

    Duran I;Kortmansky J;Singh D;Hirte H

  • Treatment of Nonresectable Hepatocellular Carcinoma with Intrahepatic 90Y-Microspheres

    Janet E. Dancey;Frances A. Shepherd;Karen Paul;Kenneth W. Sniderman

  • A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

    Ramesh K. Ramanathan;Chandra P. Belani;Deepti A. Singh;Michael Tanaka

Frequent Co-Authors

Patrick Y. Wen
Patrick Y. Wen Harvard University
Susan M. Chang
Susan M. Chang University of California, San Francisco
Michael D. Prados
Michael D. Prados University of California, San Francisco
Lillian L. Siu
Lillian L. Siu University of Toronto
Lincoln Stein
Lincoln Stein Ontario Institute for Cancer Research
John Douglas Mcpherson
John Douglas Mcpherson University of California, Davis
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Suzanne Kamel-Reid
Suzanne Kamel-Reid University Health Network
Gregory R. Pond
Gregory R. Pond McMaster University
Thomas J. Hudson
Thomas J. Hudson Ontario Institute for Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medicine, there are a variety of online degrees and career pathways to consider. Many students explore options like nursing, healthcare administration, nutrition, and nurse practitioner roles, all of which play critical parts in the healthcare ecosystem.

If you’re pursuing nursing but want to avoid extensive entrance exams, some may benefit from nursing school that don't require teas. These programs can make the application process more accessible, especially for those balancing other responsibilities.

For those interested in organizational leadership, healthcare administration degree programs offer flexible, accelerated pathways to enter the growing field of healthcare management. These degrees are ideal for future hospital managers, administrators, or policy makers.

Registered nurses looking to specialize further may consider rn to np programs, which provide an efficient route to become a Nurse Practitioner through bridge courses designed for working professionals.

Nutrition is another vital area; there are a wide range of online nutrition degree programs for those passionate about dietetics and wellness. These programs enable students to learn evidence-based strategies for promoting health at individual and community levels.

Best Scientists Citing Janet Dancey

Trending Scientists

Recently Published Articles